EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action

Angela Corona, Rita Meleddu, Olivier Delelis, Frederic Subra, Filippo Cottiglia, Francesca Esposito, Simona Distinto, Elias Maccioni, Enzo Tramontano

Frontiers in Cellular and Infection Microbiology · 23.06.2023 · 13

DOI: 10.3389/fcimb.2023.1193280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 23.06.2023. Verfasst von Angela Corona und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy. Hauptthemen laut MEDLINE: Reverse Transcriptase Inhibitors, HIV-1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the effort to identify and develop new HIV-1 inhibitors endowed with innovative mechanisms, we focused our attention on the possibility to target more than one viral encoded enzymatic function with a single molecule. In this respect, we have previously identified by virtual screening a new indolinone-based scaffold for dual allosteric inhibitors targeting both reverse transcriptase-associated functions: polymerase and RNase H. Pursuing with the structural optimization of these dual inhibitors, we synthesized a series of 35 new 3-[2-(4-aryl-1,3-thiazol-2-ylidene)hydrazin-1-ylidene]1-indol-2-one and 3-[3-methyl-4-arylthiazol-2-ylidene)hydrazine-1-ylidene)indolin-2-one derivatives, which maintain their dual inhibitory activity in the low micromolar range. Interestingly, compounds 1a, 3a, 10a, and 9b are able to block HIV-1 replication with EC 50 < 20 µM. Mechanism of action studies showed that such compounds could block HIV-1 integrase. In particular, compound 10a is the most promising for further multitarget compound development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reverse Transcriptase InhibitorsHIV-1Structure-Activity RelationshipOxindolesHIV Reverse TranscriptaseVirus ReplicationIndoles

Stichwörter der Autor:innen

IN inhibitorsRT inhibitorsantiviral agentsdrug designmultitarget inhibitors

Substanzen

Reverse Transcriptase InhibitorsOxindolesHIV Reverse Transcriptaseindolin-2-oneIndoles

Autor:innen und Institutionen

  • Department of Life and Environmental Sciences, University of Cagliari, Monserrato, Italy.
  • Laboratory of Biology and Applied Pharmacology (LBPA), Ecole Normale Supérieure (ENS) Cachan, Centre National de la Recherche Scientifique (CNRS), Cachan, France.

Zitieren

APA

Corona, A., Meleddu, R., Delelis, O., Subra, F., Cottiglia, F., Esposito, F., Distinto, S., Maccioni, E., & Tramontano, E. (2023). 5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1193280

Vancouver

Corona A, Meleddu R, Delelis O, Subra F, Cottiglia F, Esposito F, et al. 5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1193280

BibTeX
@article{Corona2023,
  author = {Corona, Angela and Meleddu, Rita and Delelis, Olivier and Subra, Frederic and Cottiglia, Filippo and Esposito, Francesca and Distinto, Simona and Maccioni, Elias and Tramontano, Enzo},
  title = {5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1193280}
}
Kostenlos starten →